AI Drug-Discovery Firm Chai Raises $130 Million Series B

Why are you doubling down and what is the money being used for. Well, first of all, thanks so much for for having us here. It's a really exciting time for the company we're coming out of this year with a series of research breakthroughs where we've now shown that we can use A.I. to design molecules that we never even thought was going to be possible. So we're really using this money to double down on that research agenda.The models show no signs of of slowing down, and then also really growing the team and ...